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Abstract
Rationale: Air pollution has been associated with increased
prevalence of type 2 diabetes; however, the mechanisms remain
unknown. We have shown that acute ozone exposure in rats
induces release of stress hormones, hyperglycemia, leptinemia,
and glucose intolerance that are associated with global
changes in peripheral glucose, lipid, and amino acid
metabolism.
Objectives: To examine ozone-induced metabolic derangement
in humans using serum metabolomic assessment, establish
human-to-rodent coherence, and identify novel nonprotein
biomarkers.
Methods: Serum samples were obtained from a crossover
clinical study that included two clinic visits (n = 24 each) where
each subject was blindly exposed in the morning to either filtered
air or 0.3 parts per million ozone for 2 hours during 15-minute
on-off exercise. Serum samples collected within 1 hour after
exposure were assessed for changes in metabolites using a
metabolomic approach.
Measurements andMainResults:Metabolomic analysis revealed
that ozone exposure markedly increased serum cortisol and
corticosterone together with increases in monoacylglycerol, glycerol,
and medium- and long-chain free fatty acids, reflective of lipid
mobilization and catabolism.Additionally, ozone exposure increased
serum lysolipids, potentially originating from membrane lipid
breakdown. Ozone exposure also increased circulating
mitochondrial b-oxidation–derived metabolites, such as
acylcarnitines, together with increases in the ketone body
3-hydroxybutyrate. These changes suggested saturation of
b-oxidation by ozone in exercising humans.
Conclusions: As in rodents, acute ozone exposure increased stress
hormones and globally altered peripheral lipid metabolism in
humans, likely through activation of a neurohormonally mediated
stress response pathway. The metabolomic assessment revealed new
biomarkers and allowed for establishment of rodent-to-human
coherence.
Clinical trial registered with www.clinicaltrials.gov (NCT 01492517).
Keywords: air pollution; stress response; lipid mediators; fatty
acids
Several epidemiologic studies nationally and
internationally have predicted a link
between air pollution and prevalence of
diabetes (1–6). It is apparent that the
conventional risk factors, such as sedentary
lifestyle, obesogenic high-caloric diets,
and/or genetics, alone do not fully explain
the causal relationship. The contribution of
stress and environmental factors has been
postulated. Near-road air pollution
exposure has also been linked to diabetes
(7–9) and a recent study has associated
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roadway proximity with hyperglycemia in
women (10). Although both particulate matter
and gaseous pollutants have been associated
with diabetes, in one study this association
was presumed to be stronger with gaseous
pollutants than particulate matter (11).
Subchronic ambient particulate matter
exposure studies using rodent models
have shown increased adipose and brain
inflammation, and liver insulin resistance
(12, 13). It has been postulated that
pulmonary injury and inflammation,
following inhalation of air pollutants, leads
to increased release of cytokines and
biologically active mediators causing
systemic inflammation and metabolic
effects. However, most air pollution studies
examining circulating cytokines fail to
demonstrate their increases in the blood.
More recently, epidemiologic and
experimental studies have associated
inhaled pollutants with a variety of neural
outcomes (14–17). Specifically, exposure
to ozone activates the nucleus tractus
solitarius and stress responsive regions of
the hypothalamus through stimulation of
pulmonary vagal C fibers (18). Acute ozone
exposure can increase levels of circulating
stress hormones, such as epinephrine and
corticosterone, in rats (19–21). Ozone
exposure also induces cardiac autonomic
effects in humans (22); hypothermia and
bradycardia in rats (23); and leptinemia,
hyperglycemia, glucose intolerance, and
global changes in circulating metabolites
involved in peripheral glucose, lipid, and
amino acid metabolism in rats (20). These
changes are reflective of classical stress
response–mediated homeostatic alterations
involving activation of sympathetic neurons
and hypothalamus-pituitary-adrenal (HPA)
axis (20).
We have previously performed global
metabolomic assessment of serum to
characterize the metabolic responses to
ozone and to gain mechanistic insights in
rats (20). The goal of this exploratory study
was to perform a global metabolomic
assessment of archived human serum
samples from a prior clinical study
involving ozone exposure, and determine
ozone-induced metabolic changes in
humans, establish rodent-to-human
coherence, and identify novel nonprotein
biomarkers of ozone exposure. We
hypothesized that global metabolomic
assessment of serum samples collected after
air or ozone exposure in humans will
reveal metabolic derangements through a
neurohormonally mediated stress response,
comparable with rats. Because most human
ozone exposures are performed during
intermittent exercise and daylight cycle,
we predicted that there would be some
discrepancies in the metabolite profile of the
serum between nonexercising rats (nocturnal)
exposed during their nonactive circadian
cycle and exercising humans. Some of the
results of this study have been previously
reported in the form of an abstract (24).
Methods
Original Study Design: Study
Population and Ozone Exposure
Serum samples for this exploratory study
were obtained from Clinical Trial
NCT01492517. In this trial, subjects were
recruited under an Environmental
Protection Agency contract with Westat
Corporation (Rockville, MD). Cardiac and
pulmonary function, and systemic effects of
ozone on coagulation and inflammatory
markers have been previously reported from
this study (25). A total of 24 volunteers
were involved in the study. The protocol
and consent forms were approved by the
University of North Carolina, School of
Medicine Committee on the Protection
of the Rights of Human Subjects and the
U.S. Environmental Protection Agency’s
Institutional Review Board. The exposure
was conducted in a randomized crossover
design where two clinical visits of each
individual were separated by at least
2 weeks. During each visit, the subjects
were exposed to either 0.3 parts per million
ozone or filtered air for 2 hours in the
morning time in a blinded manner. During
the exposure, subjects alternated between
15 minutes of rest and 15 minutes of
exercise on a cycle ergometer (25).
Exposures were conducted at the U.S.
Environmental Protection Agency, Human
Studies Facility on the campus of the
University of North Carolina, Chapel Hill.
Ozone was generated by a silent electric
discharge method (model 502; Meckenheim,
Bonn, Germany). The exposure chambers
were maintained at 40% relative humidity
for all exposures. For more details of
the exposure system, see online supplement 1
and Devlin and coworkers (25).
Serum Samples and Metabolomic
Analysis
Serum samples collected before the start of
exposure, immediately postexposure (within
1 h), and during the next day morning
follow-up visit were assessed for glucose,
triglycerides, and cholesterols (LabCorp
Inc., Durham, NC) when the clinical study
was performed. In the present study,
archived serum samples collected
immediately (within 1 h) after air or
ozone exposure were used for exploratory
metabolomic assessment. These samples
were sent to Metabolon, Inc. (Durham, NC)
for global metabolomic analysis (see
METHODS section in online supplement 1).
Briefly, each sample was accessioned into
the Metabolon Laboratory Information
Management System and assigned a unique
identifier. Samples were prepared using
the automated MicroLab STAR system
from Hamilton Co. (see METHODS section
in online supplement 1). The liquid
chromatography–mass spectrometry
portion of the platform was based on a
Waters ACQUITY ultraperformance
liquid chromatography (Milford, MA)
and a Thermo Scientific Q-Exactive
high-resolution/accurate mass spectrometer
interfaced with a heated electrospray
ionization source (Waltham, MA) and
Orbitrap mass analyzer (Thermo Fisher
Scientific, Waltham, MA) operated at
35,000 mass resolution (26). The gas
At a Glance Commentary
Scientific Knowledge on the
Subject: The association between air
pollution and diabetes has motivated
research to understand how pollutants
affect metabolic processes. Ozone
levels exceed current National Ambient
Air Quality standards in many areas
and are expected to further increase
because of the warming climate trend.
What This Study Adds to the
Field: This manuscript provides new
evidence of acute systemic metabolic
effects of ozone in humans,
characterized by stress hormone–
mediated release of lipid metabolites
into the circulation. The data set shows
coherency between rat and humans in
their metabolic response to ozone
exposure. The global metabolomic
approach offers a novel tool to identify
nonprotein metabolite biomarkers of
acute pollutant exposure.
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chromatography–mass spectrometry portion
of the platform used a Thermo-Finnigan
Trace DSQ fast-scanning single-quadrupole
mass spectrometer (San Jose, CA) using
electron impact ionization. The informatics
system consisted of four major components: (1)
the Laboratory Information Management
System, (2) the data extraction and peak-
identification software, (3) data processing
tools, and (4) data interpretation and
visualization tools (see METHODS, Tables E1
and E2, and Figures E1 and E2 in online
supplement 1).
The hardware and software
foundations for these informatics
components were the LAN backbone and a
database server running Oracle 10.2.0.1
Enterprise Edition (Redwood Stores, CA).
Compounds were identified by comparison
with library entries of purified standards or
recurrent unknown entities. Peaks were
quantified using area under the curve.
Statistical analysis included log
transformation and imputation followed by
one-way analysis of variance with repeated
measures. An estimate of the false discovery
rate (q value) was calculated to take into
account the multiple comparisons that
normally occur in metabolomic-based
studies. Significant (P, 0.05) pathway
enrichment output (cumulative
hypergeometric distribution) was assessed
for each of the selected contrasts using
MetaboLync, version 1.1.2 (Metabolon Inc,
Durham, NC) (27) to determine the
metabolic processes impacted by ozone.
Serum samples collected immediately
post air or ozone exposure were also
analyzed for insulin, leptin, IL-6, and tumor
necrosis factor-a using human-specific
antibody-based electrochemiluminescence
assays (Meso Scale Discovery, Gaithersburg,
MD) according to manufacturer instructions.
Results
Demographics of Human Subjects
The clinical study from which serum
samples were obtained included 24 healthy,
young adult participants: 20 males and
4 females (Table 1). The average age of
the subjects was 25.6 with a range of
22–30 years. Weights averaged 78.5 kg with
a range from 50.7 to 97.3 kg. Eleven
subjects had a body mass index between
18.5 and 24.9, and 13 subjects were between
25 and 29.9 (see online supplement 2 for
details on individual subjects). Most of the
subjects never smoked. Only three subjects
were previous smokers, all before the year
2006. All subjects participated in weekly
exercise: 2 mild level (90–180 min/wk),
9 moderate level (180–360 min/wk),
and 13 high level (.360 min/wk).
Participants did not have a recent
history of prescription medication use,
cardiopulmonary disease, or allergies as
determined by a detailed medical history
and physical examination. Their specific
characteristics are summarized in Table 1
and detailed in online supplement 1.
Heart rate, blood pressure, and serum
glucose, triglycerides, and cholesterols
measured before, immediately after air or
ozone exposure, and after a 1-day follow-up
visit for each subject are provided as
line graphs in online supplement 1 (see
Figures E3 and E4) and individual
subject’s data in online supplement 2.
There were no marked pre or post air
or ozone exposure differences noted in
heart rate and blood pressure; however,
between-subject variability was noted in
the levels of triglycerides and cholesterols.
Between-subject glucose levels varied
slightly at preexposure time but not
after postexposure or next day follow-up
visit.
Ozone Exposure Increases
Circulating Cortisol but Does Not
Change Cytokines or Homeostatic
Model Assessment for Insulin
Resistance
Cortisol and corticosterone were
significantly increased in the serum samples
collected after ozone exposure when
compared with air (Figure 1). In addition,
a 1.62-fold increase in corticosterone
metabolite 11-dehydrocorticosterone, but
not cortisone (see online supplement 2),
suggests HPA axis involvement in acute
ozone-induced extrapulmonary effects.
Serum levels of tumor necrosis factor-a and
IL-6 as reported earlier (25) showed no
significant difference between air and ozone
immediately postexposure (data not
shown). Serum leptin and insulin (see
Figure E5 in online supplement 1 and
data in online supplement 2) were not
significantly different between air and
ozone samples immediately postexposure.
High individual sample variability was
noted for three to four individuals in the
levels of insulin and leptin. Homeostatic
model assessment for insulin resistance
provided no significant differences between
air and ozone exposure (see Figure E5 in
online supplement 1 for line graph and
online supplement 2 for data).
Correlations of Subject
Characteristics with Individual
Metabolites and Ozone-induced
Changes
We attempted to correlate ozone-induced
changes (fold-increase) in selected
metabolites, including steroid hormones,
with individual subject’s body mass index,
but no significant relationships seemed to
occur (see Figures E6A–6E in online
supplement 1). Although the number of
subjects included in the study was small,
especially when stratified for their prior
exercise habit (as mild, moderate, or heavy)
or sex, we have provided the correlation
plots and results in Figures E7A–7E and
E8A–8E and RESULTS section of online
supplement 1. Likewise, circulating levels
Table 1. Demographics of Study
Participants*
Demographics
n or Mean 6 SD
(n = 24)
Sex
Male 20
Female 4
Race
White 22
Hispanic 2
Smoking
Never smoker 21
Former smoker† 3
Medication‡ 3
Exercisex
Mild 2
Moderate 9
Heavy 13
Age, yr 25.66 3.8
Height, cm 177.96 9.3
Weight, kg 78.56 13.9
Body mass index 24.76 3.0
18.5–24.9 11
25–29.9 13
Systolic 121.06 8.4
Diastolic 73.96 6.8
Heart rate, bpm 73.46 14.4
Definition of abbreviation: bpm = beats per
minute.
*For details on individual subject demographics,
see online supplement 1.
†Smoked before the year 2006.
‡Currently on medication (multivitamins and/or
Lexapro).
xExercise levels: mild, 90–180 minutes per
week; moderate, 180–360 minutes per week,
heavy, .360 minutes per week.
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of metabolites (glucose, triglycerides, and
cholesterols) after air or after ozone
exposure were analyzed for correlations
with body mass index, prior exercise habit,
and sex, and these plots are provided in
Figures E9–E11 in online supplement 1. No
significant differences were noted between
air and ozone exposure for preexposure
normalized glucose, triglycerides, and lipids
levels (see online supplement 2 for all
individual subject’s clinical data).
Ozone Exposure Changes the Profile
of Circulating Metabolites
There were 663 compounds of known
identity detected in the human serum
samples (see online supplement 2 for all
original data, normalized data, heat maps,
and scatter plots). Of those, statistically
significant differences were found for 121
biochemicals (P, 0.05) between air and
ozone exposure as determined by analysis
of variance. Specifically, 85 were increased
and 36 were decreased after ozone
exposure compared with air. There were
also several biochemicals for which the
difference between the air and ozone
exposures approached significance
(0.05, P, 0.10; 23 increased and
29 decreased). A pathway enrichment
analysis using MetaboLync (27) indicated
seven biochemical pathways (sphingolipid
metabolism, endocannabinoid synthesis,
fatty acid metabolism, b-oxidation,
dicarboxylic acid metabolism, steroid
hormone biosynthesis, and phospholipid
metabolism) to be significantly altered by
ozone exposure (Figure 2). All of these
pathways are associated with lipid
metabolism.
Ozone Exposure Increases
Circulating Free Fatty Acids and
Lysolipids in Humans
One of the most consistent and strongest
effects associated with ozone exposure in
this study was the pronounced increases in
serum free fatty acids (Table 2). There were
significant (P, 0.05) increases in medium-
and long-chain free fatty acids in the serum
samples collected after ozone exposure
relative to air, along with a significant
increase in serum glycerol, a marker of
lipolysis (Table 2). Additionally, higher
levels of a variety of lysolipids were found
in the serum samples collected after ozone
exposure relative to air (Table 3), which
may indicate membrane phospholipid
hydrolysis contributing to fatty acid
generation. Finally, increasing trends
were also noted in sphinganine (P = 0.0511)
and sphingosine 1-phosphate (P, 0.00005)
in combination with elevated long-chain
fatty acids in the serum samples obtained
after ozone exposure relative to the
filtered air.
Ozone Exposure during Intermittent
Exercise Increases Fatty Acid
Oxidation in Humans
There were significant changes in
biochemicals associated with fatty acid
b-oxidation (Table 4). These changes
included significantly higher levels of
octanoylcarnitine, decanoylcarnitine, and
cis-4-decanoylcarnitine together with a
trend of an increase in acetylcarnitine
(P = 0.079; a surrogate for the fatty acid
oxidation end product acetyl-CoA) in
the serum samples collected after ozone
relative to air exposure. Ozone exposure
was also associated with increases in
serum laurylcarnitine, myristoylcarnitine,
palmitoylcarnitine, oleoylcarnitine,
linoleoylcarnitine, and myristoleoylcarnitine.
Long-chain fatty acids (.12 carbons) are
conjugated with carnitine to facilitate
transport into the mitochondrial matrix
where they may undergo fatty acid
b-oxidation for energy. These changes were
also accompanied by lower levels of
carnitine in the serum samples collected
after ozone exposure, which may be a
marker of increased use for acylcarnitine
conjugation.
Moreover, the dicarboxylates, azelate,
and 2-hydroxyglutarate were significantly
(P, 0.05) increased in the serum after
ozone exposure when compared with air
(Table 4), and may suggest that the
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Figure 1. Acute 2-hour ozone exposure increases serum levels of the stress hormones cortisol (A) and corticosterone (B) in humans. Box-and-whisker
plots convey the spread of the data with the interquartile range represented by the box and the range of the data shown by the whiskers (n = 24 per
group). Outlier values are defined as those that exceed, in either direction, 1.5 times the interquartile range (shown as open circles in each plot). The
solid bar across the box represents the median value, and 1 symbol represents the mean. *Significantly different from air group (P, 0.05). For
each biochemical, data are median scaled with the median value across all samples set to 1.0. The y-axis thus reflects scaled intensity for each
metabolite.
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b-oxidation process was saturated, thereby
shifting to fatty acid v-oxidation. Taken
together, these findings support increased
fatty acid b-oxidation for energy generation
following the 2-hour ozone exposure during
intermittent exercise. Further, indication of
increased fatty acid b-oxidation was revealed
by the elevation in the ketone body,
3-hydroxybutyrate (Table 4), a marker of
hepatic fatty acid b-oxidation, which can
accumulate in cases where the capacity of
the tricarboxylic acid cycle is overwhelmed
by the availability of substrate.
Ozone Exposure Increased
Polyunsaturated Fatty Acids in
the Serum
In addition to the observed increases in
free fatty acids and fatty acid oxidation
by-products, n3 and n6 polyunsaturated
fatty acids were also significantly (P, 0.05)
increased in the serum from ozone-exposed
subjects relative to air and may contribute
to production of inflammatory mediators
(Figure 3). These included linolenate
alpha or gamma (18:3n3 or n6; Figure 3A),
eicosapentaenoate (20:5n3; Figure 3B),
docosapentaenoate (n3 22:5n3; Figure 3C),
docosahexaeonate (22:6n3; Figure 3D), linoleate
(18:2n6; Figure 3E), dihomo-linolenate
Table 2. Acute Ozone Exposure Increases Circulating Free Fatty Acids and Monoacylglycerols in Humans
Free Fatty Acids Metabolite Fold Change: Ozone/Air* P Value† q Value
Medium-chain fatty acid
Caproate (6:0) 1.17 0.0041 0.048
Laurate (12:0) 1.17 0.0649 0.218
5-Dodecenoate (12:1n7) 1.57 0.0058 0.053
Long-chain fatty acid
Myristate (14:0) 1.42 0.0102 0.072
Myristoleate (14:1n5) 1.80 0.0005 0.025
Palmitoleate (16:1n7) 1.72 0.0019 0.042
Margarate (17:0) 1.30 0.0097 0.070
10-Heptadecenoate (17:1n7) 1.48 0.0041 0.048
Oleate (18:1n9) 1.38 0.0014 0.034
Cis-vaccenate (18:1n7) 1.20 0.0759 0.238
10-Nonadecenoate (19:1n9) 1.54 0.0042 0.048
Eicosenoate (20:1n9 or 11) 1.44 0.0082 0.065
Fatty acid, monohydroxy
3-Hydroxyoctanoate 1.48 0.0195 0.115
3-Hydroxydecanoate 1.78 0.0031 0.045
3-Hydroxylaurate 1.77 0.0021 0.043
Glycerolipid metabolism Glycerol 1.34 0.0072 0.059
Monoacylglycerol
1-Stearoylglycerol (1-monostearin) 2.32 0.0046 0.048
2-Stearoylglycerol (2-monostearin) 1.89 0.0028 0.044
1-Oleoylglycerol (1-monoolein) 1.56 0.0000 0.004
2-Oleoylglycerol (2-monoolein) 1.85 0.0047 0.048
*Values indicate relative fold differences for each biochemical between ozone and filtered air samples (n = 24 per group). A fold change .1 indicates an
increase.
†When P, 0.05, the change is considered significant.
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Figure 2. Ozone altered lipid metabolism pathways in humans. Pathway enrichment analysis (using MetaboSync) identified seven specific biochemical
pathways (sphingolipid metabolism, endocannabinoid synthesis, fatty acid metabolism, b-oxidation, dicarboxylic acid metabolism, steroid hormone
biosynthesis, and phospholipid metabolism) as having a significant (P, 0.05) fold enrichment value for ozone exposure compared with air. This analysis
was based on several parameters including the total number of detected metabolites in the study and selected pathway, and the abundance of total
metabolites associated with each pathway.
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(20:3n3 or n6; Figure 3F), and arachidonate
(20:4n6; Figure 3G).
Discussion
Epidemiologic studies have associated air
pollutants with increased prevalence of type
2 diabetes and changes in markers of insulin
resistance (1–9, 28, 29). However,
controlled human studies examining
systemic metabolic effects and potential
mechanisms have not been performed.
Several environmental stressors over a
long period of time are postulated to be
interactively involved in the development
of insulin resistance and are linked to
lipidemia and high blood glucose. We have
recently reported that acute ozone exposure
in rodents produces systemic homeostatic
changes in circulating metabolites reflective
of activation of neuronal stress response
Table 3. Ozone Exposure Elevates Circulating Lysolipid and Sphingolipid Metabolites in Humans
Metabolite Fold Change: Ozone/Air* P Value† q Value
Lysolipids
1-Pentadecanoylglycerophosphocholine (15:0) 1.10 0.0901 0.256
1-Palmitoylglycerophosphocholine (16:0) 1.08 0.0035 0.047
2-Palmitoylglycerophosphocholine (16:0) 1.06 0.0787 0.239
1-Palmitoleoylglycerophosphocholine (16:1) 1.11 0.0313 0.155
1-Margaroylglycerophosphocholine (17:0) 1.24 0.0004 0.023
1-Stearoylglycerophosphocholine (18:0) 1.16 0.0027 0.044
2-Stearoylglycerophosphocholine (18:0) 1.19 0.0108 0.075
1-Oleoylglycerophosphocholine (18:1) 1.18 0.0014 0.034
2-Oleoylglycerophosphocholine (18:1) 1.11 0.0665 0.219
1-Linoleoylglycerophosphocholine (18:2n6) 1.08 0.0614 0.218
2-Linoleoylglycerophosphocholine (18:2n6) 1.14 0.0324 0.158
1-Linolenoylglycerophosphocholine (18:3n3) 0.82 0.0856 0.250
2-Linolenoylglycerophosphocholine (18:3n3) 0.85 0.0406 0.176
1-Nonadecanoylglycerophosphocholine (19:0) 1.29 0.0046 0.048
1-Dihomo-linoleoylglycerophosphocholine (20:2n6) 1.22 0.0007 0.028
1-Arachidoylglycerophosphocholine (20:0) 1.44 0.0112 0.076
1-Eicosenoylglycerophosphocholine (20:1n9) 1.33 0.0029 0.044
2-Eicosenoylglycerophosphocholine (20:1n9) 1.48 0.0012 0.033
1-Eicosatrienoylglycerophosphocholine (20:3) 1.22 0.0023 0.044
2-Eicosatrienoylglycerophosphocholine (20:3) 1.20 0.0009 0.032
1-Arachidonoylglycerophosphocholine (20:4n6) 1.15 0.0006 0.028
2-Arachidonoylglycerophosphocholine (20:4n6) 1.16 0.0002 0.014
1-Eicosapentaenoylglycerophosphocholine
(20:5n3)
1.17 0.0378 0.170
Sphingolipid metabolism Sphingosine 1-phosphate 1.37 0.0000 0.042Sphinganine 1.20 0.0511 0.198
*Values indicate relative fold differences for each biochemical between ozone and filtered air samples (n = 24 per group). A fold change .1 indicates an
increase; fold change ,1 indicates a decrease.
†When P, 0.05, the change is considered significant.
Table 4. Ozone Exposure during Intermittent Exercise Increases Circulating b-Oxidation Metabolites in Humans
Pathway Metabolite Fold Change: Ozone/Air* P Value† q Value
Fatty acid metabolism (acylcarnitine)
Acetylcarnitine 1.09 0.0787 0.239
Hexanoylcarnitine 1.22 0.0827 0.246
Octanoylcarnitine 1.32 0.0224 0.127
Decanoylcarnitine 1.42 0.0132 0.085
Cis-4-decenoylcarnitine 1.27 0.0235 0.132
Laurylcarnitine 1.79 0.0094 0.069
Myristoylcarnitine 1.57 0.0360 0.169
Palmitoylcarnitine 1.25 0.0319 0.157
Oleoylcarnitine 1.38 0.0022 0.043
Linoleoylcarnitine 1.31 0.0130 0.085
Myristoleoylcarnitine 1.81 0.0051 0.048
Fatty acid, dicarboxylate 2-Hydroxyglutarate 1.26 0.0320 0.187Azelate 1.55 0.0002 0.004
Carnitine metabolism Carnitine 0.92 0.0102 0.072
Ketone bodies 3-Hydroxybutyrate 1.82 0.0451 0.187
*Values indicate relative fold differences for each biochemical between ozone and filtered air samples (n = 24 per group). A fold change .1 indicates an
increase; fold change ,1 indicates a decrease.
†When P, 0.05, the change is considered significant.
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pathways (19, 20). The goal of the current
study was to determine if metabolomic
assessment of serum samples obtained from
a prior clinical study where humans were
acutely exposed to ozone show similar
systemic metabolic alterations as rodents.
Serum metabolomic analysis revealed
increases in circulating cortisol and
corticosterone, but not cortisone, in samples
collected after ozone exposure, reflective
of an activation of a neurohormonally
mediated stress response in humans.
Pathway analysis of metabolites significantly
(P, 0.05) changed in serum after ozone
exposure implicated altered lipid metabolic
processes. As observed in rodents, increased
levels of several circulating free fatty acids
and glycerols in the serum from ozone-
exposed individuals suggested stimulation
of adipose lipolysis of triglyceride stores
and their liberation into the circulation.
Increased lysolipids, likely released from
hydrolysis of cellular and membrane
phospholipids, and serum polyunsaturated
fatty acids in ozone-exposed humans may
be linked to proinflammatory mechanisms.
Unlike rodents, samples obtained from
humans who exercised intermittently
during ozone exposure showed elevated
circulating metabolites of b-oxidation, such
as ketone bodies, dicarboxylates, and
metabolites of v-oxidation. No ozone
effects were noted in homeostatic model
assessment for insulin resistance. Overall,
this study demonstrates that ozone
exposure in humans is associated with
linolenate (18:3n3)
linoleate (18:2n6)
DHGLA (20:3n6)
AA (20:4n6)
(22:5n6)
13-HODE
EPA (20:5n3)
DPA (22:5n3)
DHA (22:6n3)
HEPEs
LTs5
n3 PUFAs
n6 PUFAs
lox elongase
lox
cox
lox
peroxisomal   -
oxidation
peroxisomal   -
oxidation
coxPGs3
TXs3
HETEs
LTs4
PGs2
TXs2
5 desaturase
E
Air
0.5
1.0
1.5
2.0
2.5
0.0
Sc
al
ed
 D
en
si
ty
Ozone 
+
+
A 4
3
2
1
0
Sc
al
ed
 D
en
si
ty
Air Ozone 
+
+
F
Air Ozone 
0.5
1.0
1.5
2.0
2.5
0.0
Sc
al
ed
 D
en
si
ty
+
+
B
4
3
5
2
1
0
Sc
al
ed
 D
en
si
ty
Air Ozone 
+
+
G
Air Ozone 
0.5
1.0
1.5
2.0
2.5
0.0
Sc
al
ed
 D
en
si
ty
+
+
C
4
3
5
2
1
0
Sc
al
ed
 D
en
si
ty
Air Ozone 
+
+
D
2.5
2.0
1.5
3.5
3.0
1.0
0.5
0.0
Sc
al
ed
 D
en
si
ty
Air Ozone 
+
+
Δ
β
β
Figure 3. Acute ozone exposure increases circulating polyunsaturated lipids in humans. Polyunsaturated lipids (A) linolenate (a or g; 18:3n3 or n6), (B)
eicosapentaenoate (EPA; 20:5n3), (C) docosapentaenoate (n3 DPA; 22:5n3), (D) decosahexaenoate (DHA; 22:6n3), (E) linoleate (18:2n6), (F) dihomo-
linolenate (DHGLA; 20:3n3 or n6), and (G) arachidonate (AA; 20:4n6) were increased significantly in the serum after ozone exposure in subjects. The
metabolic pathways in which these metabolites were generated are summarized in themiddle panel. Box-and-whisker plots convey the spread of the data
with the interquartile range represented by the box and the range of the data shown by the whiskers (n = 24 per group). Outlier values are defined as those
that exceed, in either direction, 1.5 times the interquartile range (shown as open circle in each plot). The solid bar across the box represents the
median value, and the 1 symbol represents the mean. For each biochemical, data are median scaled with the median value across all samples set
to 1.0. The y-axis thus reflects scaled intensity for each metabolite. Significant difference between air and ozone (P< 0.05 for A–F; P< 0.1 for G).
13-HODE= 13-hydroxy octadecadienoic acid; HETE = hydroxytetraenoic acid; PUFA = polyunsaturated fatty acid.
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increased release of stress hormones
causing lipolysis as in rodents, likely
through activation of HPA axis. Chronic
elevations of these metabolites in the
circulation might contribute to metabolic
diseases and systemic inflammation
(30, 31).
In nonexercising rats, acute ozone
exposure induces glucose intolerance and
increases circulating leptin and epinephrine
(19, 20). Both leptin and epinephrine
changes are associated with a reversible
decrease in body temperature (23),
suggesting involvement of the sympathetic
axis and changes in hypothalamic
thermoregulation. Increased corticotropin
and cortisol levels after ozone exposure
have also been noted in other rodent
studies (21, 32). In this study, humans
exposed to ozone also presented elevated
circulating cortisol and corticosterone,
suggesting the activation of the HPA axis,
similar to rats. However, unlike rats
(19, 20), no differences were noted in leptin
levels in serum samples obtained after
ozone exposure in humans (see Figure E5 in
online supplement 1). This might be caused
by the differences in the study design and
exposure protocol. The present human
study did not involve ozone exposure
during resting and exposure occurred
only for 2 hours. Acute ozone exposure
has been shown to activate central stress
responsive regions and the nucleus tractus
solitarius where pulmonary vagal nerves
terminate in the brain (18, 32). Thus,
pulmonary vagal C fibers, likely through
neurotransmission in the brain, can
stimulate sympathetic and/or the HPA axis,
leading to the release of stress hormones
from sympathetic nerve endings and also
from the adrenal gland (33, 34). As a result,
these stress hormones can target metabolic
organs in a tissue-specific manner and alter
glucose and lipid metabolism through
activation of cellular glucocorticoids and
adrenergic receptors.
Acute ozone exposure in humans
increased circulating long- and medium-
chain fatty acids as observed in rats (20).
This is likely induced through stress
hormone–mediated adipose lipolysis.
Endogenous and ingested free fatty acids
are reesterified in adipose tissue as
triacylglycerides for storage (35). During a
stress response, circulating epinephrine
and cortisol through b-adrenergic and
glucocorticoid receptors, respectively, can
increase hormone-sensitive lipase-mediated
lipolysis of adipose triglycerides into free
fatty acids and glycerol (35). Ozone-
induced elevation of free fatty acids in the
serum could lead to uptake of these lipid
metabolites by the peripheral tissues,
including liver and muscle, for oxidation. In
a previous study, we noted that genes
involved in mitochondrial metabolism and
biogenesis were markedly altered in the
livers of ozone-exposed rats (20). Because
the metabolic changes occurring
immediately following an ozone exposure
in humans are likely reversible after
termination of exposure, as noted in rats
after a single exposure (20), there is likely to
be minimal long-term impact on healthy
individuals. However, in those with
underlying metabolic impairment or those
with defects in homeostatic mechanisms,
exposure to ozone might be more impactful
and may contribute to metabolic
imbalance.
Lysolipids, also known as
lysophospholipids, were elevated in serum
samples obtained after ozone exposure,
indicating likely increased phospholipid
turnover and plasma membrane remodeling
by phospholipases. Although specific tissue
sources cannot be ascertained through
serum metabolomic assessment, these
lipids through their action on G-protein-
coupled lysophospholipid membrane
receptors have been shown to impact a
variety of cellular responses, such as
cytoskeletal integrity/stability, mitogenesis,
inflammation, energy production, and lipid
metabolism (36).
Ozone exposure also increased
circulating polyunsaturated fatty acids
(Figure 3). In the lung, ozone exposure has
been shown to increase polyunsaturated
fatty acids, which are formed by a
combination of activation of
phospholipases and inhibition of free fatty
acid esterification pathways (37, 38). The
resulting increases in arachidonic acid
metabolites can be involved in homeostatic
and acute inflammatory responses. For
example, arachidonic acid released by
phospholipase A2 is metabolized through
the lipoxygenase or cyclooxygenase
pathways to form eicosanoids, including
leukotrienes, prostaglandins, and
thromboxanes (39). Ozone exposure
was associated with significant increases
in plasma thromboxane B2, 6-keto
prostaglandin F1 alpha, and prostaglandin
E1 in guinea pigs (40). It is unclear whether
the identified mediators shown in Figure 3
of ozone-induced phospholipase activation
(41) can exert extrapulmonary effects.
Enzymes involved in lipid metabolism were
shown to be altered in a primate model after
subchronic exposure to 0.3 parts per million
ozone (42). Interestingly, it has also been
demonstrated that cortisol inhibits
phospholipase activity and prostaglandin
production (43). Because these lipids were
increased in the serum samples obtained
after ozone exposure done with intermittent
exercise in humans, but not in rats that were
exposed during inactivity, the potential
mechanism and implication of these
findings requires further studies.
Acute ozone exposure might alter
mitochondrial b-oxidation involved in
catabolism of free fatty acids. Decreases in
carnitine and increases in acylcarnitines
together with elevated 3-hydroxybutyrate,
a marker of hepatic b-oxidation, in serum
after ozone exposure relative to air
suggests changes in fatty acid oxidation
that may be attributed to mitochondrial
involvement (44). Additionally, increases
in dicarboxylic acids in serum after
ozone exposure may relate to increased
v-oxidation, a nicotinamide adenine
dinucleotide phosphate– and cytochrome
P-450–dependent process where the
omega carbon of a fatty acid is oxidized to
an alcohol and then to a carboxylic acid,
thereby generating dicarboxylic acid.
Dicarboxylic acids are produced by
peroxisomes when the supply of fatty acids
to the liver exceeds the capacity for
b-oxidation and reesterification. Because
subjects during air and ozone exposure
underwent an exercise regimen, and
exercise can influence the metabolic status,
it is likely that the ozone response was
influenced by exercise. Exercise-induced
oxidative stress (45) was postulated to
contribute to ozone-induced cytogenetic
damage to human lymphocytes after ozone
exposure (46). Interestingly, these changes
were not observed in rats exposed to ozone
(17) during inactivity. It is noteworthy that
the ozone-induced hypothermia in
nonexercising rodents exposed during
their inactive (daytime) cycle (23) may
lead to diminution of peripheral metabolic
processes (muscle), whereas this response
may not be apparent in humans exposed
during their active cycle (daytime).
There are several limitations of our
study. We only performed metabolomic
analysis post air or ozone exposure during
two clinical visits; thus, this study is not a
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complete crossover design except for
clinical measures. Ozone effects were
not determined in humans during
inactivity/resting and thus, the contribution
of exercise and interaction with ozone
cannot be assessed directly. Because we are
attempting to compare the ozone effects in
exercising humans with nonexercising
rats, only some speculation of the role of
exercise can be made. Moreover, human
exposures occurred over 2 hours, whereas
rats were exposed for 6 hours. Recently, we
have noted that as with the hypothermic
response to ozone, which is observed within
1 hour (23), metabolic changes in rats are
also apparent early, as determined after
2 hours (data not shown).
The discrepancies in effective lung
ozone dose could be partially explained by
the evidence that exercising humans will
inhale a larger ozone dose relative to
nonexercising rats (47). We have
demonstrated that acute ozone-induced
metabolic changes are reversible the
following day despite a continued
inflammatory response in rodents (20),
but we were neither able to analyze the
reversibility of these changes in humans
nor study the long-term ozone effects.
In a previous study involving subchronic
episodic exposure of Brown Norway rats,
we noted that glucose intolerance still
occurred after 12 weekly exposures (19).
Because humans are exposed episodically
to ozone throughout their lifetime, it is
important to determine if persistent
episodic metabolic derangement
contributes to metabolic diseases.
This study is the first to characterize the
global metabolic derangement in humans
after ozone exposure using a metabolomic
assessment. We show that ozone exposure
in humans is associated with marked
increases in a variety of fatty acids in the
circulation together with increases in
cortisol and corticosterone, suggesting
activation of the neurohormonal stress
response pathway and subsequent changes
in peripheral metabolic homeostasis. This
study establishes the coherence between
humans and rodents in ozone-induced
stress hormone increase and metabolic
effects. Through this approach, novel
biomarkers, such as cortisol, free fatty acids,
monoacylglycerols, and lysolipids, for acute
pollutant-induced health effects are
identified. Further studies are needed to
examine if these responses persist during
chronic exposure and contribute to
metabolic disorders. n
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